肿瘤指南

订阅

MedSci主页 / 所有栏目 / 肿瘤指南

《2022 ,美国国立综合癌症网络卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》解读

2022-03-02 中山大学孙逸仙纪念医院妇产科 中国实用妇科与产科杂志

卵巢癌妇科肿瘤输卵管癌原发性腹膜癌

近日,美国国立综合癌症网络（National Comprehensive Cancer Network,NCCN）公布了《2022 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》。

中文标题：

《2022 ,美国国立综合癌症网络卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》解读

发布机构：

中山大学孙逸仙纪念医院妇产科

发布日期：

2022-03-02

简要介绍：

近日,美国国立综合癌症网络（National Comprehensive Cancer Network,NCCN）公布了《2022 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》。新版指南在卵巢癌化疗、基因检测等方面有重要更新。现对新版指南进行简要解读。

相关资料下载：
[AttachmentFileName(sort=1, fileName=《2022 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f558d1c002386972, title=《2022 ,美国国立综合癌症网络卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》解读, enTitle=, guiderFrom=中国实用妇科与产科杂志, authorId=0, author=, summary=近日,美国国立综合癌症网络（National Comprehensive Cancer Network,NCCN）公布了《2022 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》。, cover=https://img.medsci.cn/2022319/1647670629677_5579292.png, journalId=0, articlesId=null, associationId=2340, associationName=中山大学孙逸仙纪念医院妇产科, associationIntro=中山大学孙逸仙纪念医院妇产科, copyright=0, guiderPublishedTime=Wed Mar 02 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">近日,美国国立综合癌症网络（National Comprehensive Cancer Network,NCCN）公布了《2022 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》。新版指南在卵巢癌化疗、基因检测等方面有重要更新。现对新版指南进行简要解读。</span></p>, tagList=[TagDto(tagId=359, tagName=卵巢癌), TagDto(tagId=1983, tagName=妇科肿瘤), TagDto(tagId=37659, tagName=输卵管癌), TagDto(tagId=38822, tagName=原发性腹膜癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21052, categoryName=梅斯医学-卵巢癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5193, appHits=127, showAppHits=0, pcHits=623, showPcHits=5064, likes=0, shares=22, comments=5, approvalStatus=1, publishedTime=Sat Mar 19 15:15:00 CST 2022, publishedTimeString=2022-03-02, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Mar 19 14:18:36 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 09:37:53 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《2022 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》解读.pdf)])
《2022 NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南（第1版）》解读.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1215375, encodeId=c8ec12153e5f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Thu Apr 28 17:15:19 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209893, encodeId=99b612098938e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5eb6306387, createdName=143298_3232, createdTime=Sat Apr 09 21:27:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207089, encodeId=2bf3120e0890e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:49:30 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204531, encodeId=f72b1204531b8, content=感谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 08:57:23 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-04-28 145c4511m52暂无昵称

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1215375, encodeId=c8ec12153e5f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Thu Apr 28 17:15:19 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209893, encodeId=99b612098938e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5eb6306387, createdName=143298_3232, createdTime=Sat Apr 09 21:27:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207089, encodeId=2bf3120e0890e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:49:30 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204531, encodeId=f72b1204531b8, content=感谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 08:57:23 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-04-09 143298_3232

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1215375, encodeId=c8ec12153e5f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Thu Apr 28 17:15:19 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209893, encodeId=99b612098938e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5eb6306387, createdName=143298_3232, createdTime=Sat Apr 09 21:27:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207089, encodeId=2bf3120e0890e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:49:30 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204531, encodeId=f72b1204531b8, content=感谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 08:57:23 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-03-30 56446_2968

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1215375, encodeId=c8ec12153e5f2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/27/b2b1f0b023d29a62a644b12d465050c9.jpg, createdBy=93c35086601, createdName=145c4511m52暂无昵称, createdTime=Thu Apr 28 17:15:19 CST 2022, time=2022-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1209893, encodeId=99b612098938e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e5eb6306387, createdName=143298_3232, createdTime=Sat Apr 09 21:27:04 CST 2022, time=2022-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207089, encodeId=2bf3120e0890e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:49:30 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204531, encodeId=f72b1204531b8, content=感谢分享，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=936e6556711, createdName=ms7000000490578574, createdTime=Mon Mar 21 08:57:23 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-03-21 ms7000000490578574

    感谢分享，学习了

    0

相关指南

2021年《国际妇产科联盟（FIGO）妇科恶性肿瘤指南》联合《美国国立综合癌症网络指南》解读卵巢癌、输卵管癌及原发性腹膜癌的诊治进展

首都医科大学附属北京妇产医院/北京妇幼保健院妇瘤科 · 2022-03-05

《FIGO 2021妇癌报告》——卵巢癌、输卵管癌、腹膜癌诊治指南解读

中山大学孙逸仙纪念医院妇科肿瘤专科 · 2022-03-02

中国家族遗传性肿瘤临床诊疗专家共识（2021年版）（2）—家族遗传性卵巢癌

中国抗癌协会家族遗传性肿瘤专业委员会 · 2021-12-25

2021 欧洲专家共识：一线BRCA/同源重组缺陷检测

国外肿瘤科相关专家小组（统称） · 2021-11-30

PARP抑制剂不良反应管理的中国专家共识

中国抗癌协会妇科肿瘤专业委员会 · 2021-11-01

上皮性卵巢癌PARP抑制剂相关生物标志物 检测的中国专家共识 2020

中国抗癌协会(Chinese Anti-cancer Association) · 2021-09-01